✦ LIBER ✦

PAR5 COST-EFFECTIVENESS OF ADALIMUMAB (HUMIRATM) IN THE TREATMENT OF US PATIENTS WITH RHEUMATOID ARTHRITIS (RA)

✍ Scribed by N Bansback; A Brennan; N Sengupta

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PAR10 THE COST-UTILITY OF ADALIMUMAB (HU

✍ M Aagren; A Davies; F Pang; B Winding 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

Cost effectiveness of adalimumab in the

✍ Bansback, N J 📂 Article 📅 2005 🏛 BMJ Publishing Group 🌐 English ⚖ 150 KB

PAR5 COST-EFFECTIVENESS OF RITUXIMAB AS

✍ A Rubbert; A Kielhorn; S Schach; B Brown 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

PAR7: THE LONGTERM SAFETY AND EFFECTIVEN

✍ CA Marra; D Guh; JH Fisher; A Chalmers; J Esdaile; AH Anis 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PAR 13 COST-EFFECTIVENESS OFVALDECOXIB C

✍ RH Alten; B von Scheele; L Gaffney; F Maciver; L Niculescu 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

PAR6 COST-EFFECTIVENESS OF TREATMENT STR

✍ VD Patel; J Hay 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB